Electrophoretic gel for separating hemoglobin variants

Details Electrophoretic gel for separating hemoglobin variants Electrophoretic gel for separating hemoglobin variants

1985-11-13

1989-02-28

Howard, S.

Chemistry: electrical and wave energy

Processes and products

Electrostatic field or electrical discharge

B01D 5702, C07K 314, G01N 2726

Patent

active

048082880

ABSTRACT:
An electrophoretic gel comprising (a) at least one marine hydrocolloid processed from the class Rodophycea; and (b) a buffer. The electrophoretic gel is characterized in that the buffer (i) is selected from a group consisting of adipic acid, glutaric acid, itaconic acid, maleic acid, malic acid, malonic acid, succinic acid, succinamic acid, and tricarbalyllic acid and (ii) is present in a concentration of about 0.05 to about 0.09 M.

REFERENCES:
patent: 3527712 (1970-09-01), Renn et al.
patent: 3558459 (1971-01-01), Granstrand et al.
patent: 3873514 (1975-03-01), Chu et al.
patent: 4139440 (1979-02-01), Chrambach et al.
patent: 4189370 (1980-02-01), Boschetti
patent: 4209373 (1980-06-01), Bluestein et al.
patent: 4292154 (1981-09-01), Ambler
patent: 4319976 (1982-03-01), Gurske
The Condensed Chemical Dictionary, 8th Ed, Van Nostrand Reinhold Co., Hawley, p. 832.
Determination of Hemoglobin Variants (Citrate Agar), Corning Medical, Medfield, Mass. 02052.
Titan IV Citrate Hemoglobin Procedure, Helena Laboratories.

Affiliated with

Also associated with

Rating

Electrophoretic gel for separating hemoglobin variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Electrophoretic gel for separating hemoglobin variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Electrophoretic gel for separating hemoglobin variants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1364617